This seminar is presented in english.
 

Since the beginning of the covid-19 pandemic and the identification of the SARS-CoV-2 virus and its genome, a huge scientific effort has resulted in the development and approval for emergency use of a number of new vaccines. In the first part of this seminar, a brief presentation of the different technological platforms employed for covid-19 vaccine manufacture will be performed. Then, some of the challenges related to large scale production of these vaccines will be discussed. Finally, an open questions period will be conducted.

Biography
Omar Farnos Villar is a Research Associate at the Viral Vectors and Vaccines Bioprocessing Group of McGill University since 2017, and a former postdoctoral fellow and Research Associate at the Immuno-Virology Lab at the BioMed Research Center (Université du Québec à Montréal - 2014 to 2017). His expertise include: the design and production of recombinant subunit and viral vector-based vaccines; the design and production of chimeric virus-like particles in large-scale production systems; the development and optimization of batch and fed-batch bioprocesses in bioreactors for the production of antiviral vaccines.